These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 950461)

  • 1. Purification of native properdin by reversed affinity chromatography and its activation by proteolytic enzymes.
    Minta JO
    J Immunol; 1976 Aug; 117(2):405-12. PubMed ID: 950461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the immunochemical properties of highly purified properdin in human serum.
    Minta JO
    J Immunol; 1975 Apr; 114(4):1415-21. PubMed ID: 123262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative pathway of complement: nonenzymatic, reversible transition of precursor to active properdin.
    Götze O; Medicus RG; Müller-Eberhard HJ
    J Immunol; 1977 Feb; 118(2):525-32. PubMed ID: 839069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Native and activated properdin: interconvertibility and identity of amino- and carboxy-terminal sequences.
    Medicus RG; Esser AF; Fernandez HN; Müller-Eberhard HJ
    J Immunol; 1980 Feb; 124(2):602-6. PubMed ID: 6766162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple method for isolation of human properdin by affinity chromatography.
    Konno T; Hirai H
    J Immunol Methods; 1976; 12(1-2):47-55. PubMed ID: 792350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fractionation of human plasma proteins. I. Affinity purification of human complement properdin.
    DiScipio RG
    Protein Expr Purif; 1994 Apr; 5(2):164-9. PubMed ID: 8054850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the natural polymeric forms of human properdin and their functions in complement activation.
    Pangburn MK
    J Immunol; 1989 Jan; 142(1):202-7. PubMed ID: 2909614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rabbit properdin system: I. Identification of a new factor and purification of rabbit properdin.
    Naff GB; Hedrick SW; Ratnoff WD; Novak MA; Smith MC; Steiner C; Todd EW
    J Immunol; 1980 Jun; 124(6):2625-31. PubMed ID: 6900053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of the C3-cleaving properdin enzyme on zymosan. Demonstration that factor D is replaceable by proteolytic enzymes.
    Brade V; Nicholson A; Bitter-Suermann D; Hadding U
    J Immunol; 1974 Dec; 113(6):1735-43. PubMed ID: 4279261
    [No Abstract]   [Full Text] [Related]  

  • 10. The first component of complement. I. Purification and properties of native C1.
    Medicus RG; Chapuis RM
    J Immunol; 1980 Jul; 125(1):390-5. PubMed ID: 7381205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple procedure for isolating microgram quantities of biologically active bikunin from human urine.
    Yang L; Resnick MI; Marengo SR
    BJU Int; 2005 Sep; 96(4):647-53. PubMed ID: 16104926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant cold-adapted trypsin I from Atlantic cod-expression, purification, and identification.
    Jónsdóttir G; Bjarnason JB; Gudmundsdóttir A
    Protein Expr Purif; 2004 Jan; 33(1):110-22. PubMed ID: 14680968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and functional analysis of human properdin.
    O'Flynn J; Krol MC; Daha MR; van Kooten C
    Methods Mol Biol; 2014; 1100():161-7. PubMed ID: 24218258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Properdin research. 2. Fractionation technics for obtaining highly purified bovine properdin and bovine properdin serum].
    Zimmermann G
    Arch Exp Veterinarmed; 1972 Oct; 26(5):705-31. PubMed ID: 4665861
    [No Abstract]   [Full Text] [Related]  

  • 15. Biosynthesis of properdin.
    Farries TC; Atkinson JP
    J Immunol; 1989 Feb; 142(3):842-7. PubMed ID: 2913153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins.
    Martosella J; Zolotarjova N; Liu H; Nicol G; Boyes BE
    J Proteome Res; 2005; 4(5):1522-37. PubMed ID: 16212403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of antiserum to human properdin and demonstration of antigenic differences between the native and activated protein.
    Minta JO; Movat HZ
    Proc Soc Exp Biol Med; 1976 Feb; 151(2):411-4. PubMed ID: 56006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of C1r by proteolytic cleavage.
    Ziccardi RJ; Cooper NR
    J Immunol; 1976 Feb; 116(2):504-9. PubMed ID: 1249422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
    Kilgallon W; Amlot PL; Williams BD
    Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-step purification of superoxide dismutase from bovine erythrocytes by immunosorbent column.
    Civalleri L; Federico R; Pini C
    Biotechnol Appl Biochem; 1986 Oct; 8(5):387-91. PubMed ID: 3533118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.